Krishna Thavarajah is a Respiratory physician affiliated with Henry Ford Hospital. OpenAlex indexes 56 publications with 1,262 citations (h-index 12); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2799 W Grand Blvd
Pulm K-17
Detroit, MI 482022689
Telephone
313-916-2421Registry record last updated 10 Oct 2013.
Clinical trials
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20252 payments
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20243 payments
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
38.1%Pyridone18.3%Pirfenidone100%Part D≥40 patientsKinase inhibitor16.5%Ofev100%Part D≥45 patients+ 1 more class in this area
Metabolism & gastrointestinal
29.4%H2 blocker13.4%Famotidine100%Part D≥38 patientsCorticosteroid12.7%Prednisone100%Part D≥52 patients+ 1 more class in this area
Respiratory
29.2%Corticosteroid15%Trelegy Ellipta42%Fluticasone Propionate36%Breo Ellipta12%Budesonide-Formoterol Fumarate11%Part D<11 patientsbeta2-Adrenergic Agonist10.6%Albuterol Sulfate Hfa100%Part D≥33 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Myositis Specific Antibodies and Interstitial Lung Disease: A Single Center Retrospective Study
American Journal of Respiratory and Critical Care Medicine
2025 - Anti-Ro52 Associated Interstitial Lung Disease: A Retrospective Analysis
American Journal of Respiratory and Critical Care Medicine
2025 - Practice Patterns for Screening and Treating Interstitial Lung Disease–Related Pulmonary Hypertension at Specialty Care Centers in the United States
Annals of the American Thoracic Society
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Krishnavel Chathadi, MD
Henry Ford Hospital
Ira Wollner, MD
Henry Ford Hospital
Farzan Siddiqui, MD, PhD
Henry Ford Hospital
Thomas Lalonde, MD
Henry Ford Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”